European Journal of Pediatrics

, Volume 177, Issue 5, pp 741–746 | Cite as

Sepsis calculator implementation reduces empiric antibiotics for suspected early-onset sepsis

  • Niek B. Achten
  • J. Wendelien Dorigo-Zetsma
  • Paul D. van der Linden
  • Monique van Brakel
  • Frans B. Plötz
Original Article

Abstract

Significant overtreatment with antibiotics for suspected early onset sepsis (EOS) constitutes a persisting clinical problem, generating unnecessary risks, harms, and costs for many newborns. We aimed to study feasibility and impact of a sepsis calculator to help guide antibiotic for suspected EOS in a European setting. In this single-center study, the sepsis calculator was implemented as an addition to and in accordance with existing protocols. One thousand eight hundred seventy-seven newborns ≥ 35 weeks of gestational age were prospectively evaluated; an analogous retrospective control group (n = 2076) was used for impact analysis. We found that empirical treatment with intravenous antibiotics for suspected EOS was reduced from 4.8 to 2.7% after sepsis calculator implementation (relative risk reduction 44% (95% confidence interval 21.4–59.5%)). No evidence for changes in time to treatment start, treatment duration, or proven sepsis rates was found. Adherence to sepsis calculator recommendation was 91%.

Conclusion: Pragmatic and feasible implementation of the sepsis calculator yields a 44% reduction of empirical use of antibiotics for EOS, without signs of delay or prolongation of treatment. These findings warrant a multicenter, nation-wide, randomized study evaluating systematic use of the sepsis calculator prediction model and its effects in clinical practice outside of the USA.

What is known:

Significant overtreatment with antibiotics for suspected early-onset sepsis results in unnecessary costs, risks, and harms.

Implementation of the sepsis calculator in the USA has resulted in a significant decrease in empirical antibiotic treatment, without apparent adverse events.

What is new:

Implementation of the sepsis calculator in daily clinical decision-making in a Dutch teaching hospital is feasible in conjunction with existing protocols, with high adherence.

Antibiotic therapy for suspected early-onset sepsis was reduced by 44% following implementation of the calculator.

Keywords

Early-onset sepsis Antibiotic stewardship Neonatology Sepsis calculator 

Abbreviations

EOS

Early-onset sepsis

GBS

Group B streptococcus

Notes

Acknowledgements

We thank Sharon Tai for her help in data collection.

Authors’ contributions

NBA performed data collection, data analysis, and writing of the manuscript. WD and PL assisted in data collection and reviewed the manuscript. MB co-designed the study, helped in data collection, and reviewed the manuscript. FP designed the study and supervised in data collection, data analysis, and writing of the manuscript.

Compliance with ethical statements

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors. The study was approved by the Scientific Review Committee of Tergooi Hospitals (study number 15.58; letter reference kV/15.69).

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

The Scientific Review Committee of Tergooi Hospitals judged that the study did not fall under the Medical Research Involving Human Subjects Act, so that informed consent by patients and caregivers was not required.

References

  1. 1.
    Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily P, Apostol M, Petit S, Farley M, Lynfield R, Reingold A, Hansen NI, Stoll BJ, Shane AJ, Zell E, Schrag SJ (2011) The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J 30:937–941.  https://doi.org/10.1097/INF.0b013e318223bad2 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    van Herk W, Stocker M, van Rossum AMC (2016) Recognising early onset neonatal sepsis: an essential step in appropriate antimicrobial use. J Inf Secur 72:S77–S82.  https://doi.org/10.1016/j.jinf.2016.04.026 Google Scholar
  3. 3.
    Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PCM, Gerards LJ, Adriaanse AH, van Lingen RA, Kollée LAA (2007) Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch Dis Child Fetal Neonatal Ed 92:F271–F276.  https://doi.org/10.1136/adc.2005.088799 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Chirico G, Loda C (2011) Laboratory aid to the diagnosis and therapy of infection in the neonate. Pediatr Rep 3:1–5.  https://doi.org/10.4081/pr.2011.e1 CrossRefGoogle Scholar
  5. 5.
    National Collaborating Centre for Women’s and Children’s Health (UK) (2012) Antibiotics for early onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection. In: Packham K (ed) NICE Clinical Guidelines, 149th ed. RCOG Press, LondonGoogle Scholar
  6. 6.
    Ramasethu J, Kawakita T (2017) Antibiotic stewardship in perinatal and neonatal care. Semin Fetal Neonatal Med 22:278–283.  https://doi.org/10.1016/j.siny.2017.07.001 CrossRefPubMedGoogle Scholar
  7. 7.
    Escobar GJ, Puopolo KM, Wi S, Turk BJ, Kuzniewicz MW, Walsh EM, Newman TB, Zupancic J, Lieberman E, Draper D (2014) Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks’ gestation. Pediatrics 133:30–36.  https://doi.org/10.1542/peds.2013-1689 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E, Smith M, Escobar GJ (2011) Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 128:e1155–e1163.  https://doi.org/10.1542/peds.2010-3464 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kerste M, Corver J, Sonnevelt MC, van Brakel M, van der Linden PDM, Braams-Lisman BA, Plötz FB (2016) Application of sepsis calculator in newborns with suspected infection. J Matern Fetal Neonatal Med 7058:1–6.  https://doi.org/10.3109/14767058.2016.1149563 Google Scholar
  10. 10.
    Kuzniewicz MW, Puopolo KM, Fischer A, Walsh EM, Li S, Newman TB, Kipnis P, Escobar GJ (2017) A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr 171:365–371.  https://doi.org/10.1001/jamapediatrics.2016.4678 CrossRefPubMedGoogle Scholar
  11. 11.
    Shakib J, Buchi K, Smith E, Young PC (2015) Management of newborns born to mothers with chorioamnionitis: is it time for a kinder, gentler approach? Acad Pediatr 15:340–344.  https://doi.org/10.1016/j.acap.2014.11.007 CrossRefPubMedGoogle Scholar
  12. 12.
    Warren S, Garcia M, Hankins C (2017) Impact of neonatal early-onset sepsis calculator on antibiotic use within two tertiary healthcare centers. J Perinatol 37:394–397.  https://doi.org/10.1038/jp.2016.236 CrossRefPubMedGoogle Scholar
  13. 13.
    Money N, Newman J, Demissie S, Roth P, Blau J (2017) Anti-microbial stewardship: antibiotic use in well-appearing term neonates born to mothers with chorioamnionitis. J Perinatol 37:1–6.  https://doi.org/10.1038/jp.2017.137 CrossRefGoogle Scholar
  14. 14.
    Moons KGM, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M (2012) Risk prediction models: II. External validation, model updating, and impact assessment. Heart 98:691–698.  https://doi.org/10.1136/heartjnl-2011-301247 CrossRefPubMedGoogle Scholar
  15. 15.
    Moons KGM, Altman DG, Vergouwe Y, Royston P (2009) Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 338:b606–b606.  https://doi.org/10.1136/bmj.b606 CrossRefPubMedGoogle Scholar
  16. 16.
    NVOG (Nederlandse Vereniging voor Obstetrie en Gynaecologie), NVK (Nederlandse Vereniging Kindergeneeskunde) (2017) Preventie en behandeling van early-onset neonatale infecties (Adaptatie van de NICE-richtlijn). 1–94Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Niek B. Achten
    • 1
  • J. Wendelien Dorigo-Zetsma
    • 2
  • Paul D. van der Linden
    • 3
  • Monique van Brakel
    • 1
  • Frans B. Plötz
    • 1
  1. 1.Department of PaediatricsTergooi hospitalsBlaricumThe Netherlands
  2. 2.Department of MicrobiologyTergooi hospitalsBlaricumThe Netherlands
  3. 3.Department of Clinical PharmacologyTergooi hospitalsBlaricumThe Netherlands

Personalised recommendations